Brief

The Commission Implementing Regulation (EU) 2024/2563 amends Implementing Regulation (EU) 2022/1646 to clarify content and submission requirements for national risk-based control plans and randomised surveillance plans. The Regulation ensures consistency in data reporting, specifies minimum sampling frequencies, and adjusts rules related to pharmacologically active substances. The main purpose of this Regulation is to amend the existing implementing regulation as regards additional content of the national risk-based control plan and the national randomized surveillance plan.

This content is restricted.

Highlights content goes here...

This content is restricted.

Register of Delegated and Implementing Acts

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies